Oliviero James F III
Insider CIK 1434718 · KERX Chief Financial Officer · CKPT CEO, President and Director, Director · NVCT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVCT Nuvectis Pharma, Inc. | A Award | 2026-06-11 | 2026-06-12 | 35,000 | — | $0 | 122,828 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2025-06-12 | 2025-06-12 | 30,000 | — | $0 | 87,828 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | U Tender | 2025-05-30 | 2025-05-30 | 3,759,929 | — | $0 | 0 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2025-04-02 | 2025-04-03 | 15,090 | $4.04 | $61.0K | 3,759,929 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2025-02-10 | 2025-02-11 | 10,331 | $3.15 | $32.5K | 3,775,019 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2025-02-07 | 2025-02-11 | 9,233 | $3.41 | $31.5K | 3,785,350 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2025-01-30 | 2025-01-31 | 1,500,000 | — | $0 | 3,794,583 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | G Gift | 2024-12-20 | 2024-12-20 | 900,000 | — | $0 | 2,294,583 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2024-12-19 | 2024-12-20 | 220,230 | $3.38 | $744.4K | 3,194,583 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2024-12-18 | 2024-12-20 | 602,167 | $3.87 | $2.33M | 3,414,813 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2024-12-13 | 2024-12-17 | 2,077,700 | — | $0 | 4,016,980 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2024-06-26 | 2024-06-28 | 24,610 | $2.05 | $50.5K | 1,977,170 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | G Gift | 2024-06-26 | 2024-06-28 | 37,890 | — | $0 | 1,939,280 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2024-06-13 | 2024-06-13 | 30,000 | — | $0 | 57,828 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2024-05-24 | 2024-05-24 | 1,660,000 | — | $0 | 2,001,780 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | G Gift | 2024-02-28 | 2024-03-01 | 9,056 | — | $0 | 341,780 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2024-02-28 | 2024-03-01 | 5,894 | $2.06 | $12.1K | 350,836 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2024-02-01 | 2024-02-02 | 11,900 | $2.01 | $23.9K | 369,680 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | G Gift | 2024-02-01 | 2024-02-02 | 12,950 | — | $0 | 356,730 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2023-06-16 | 2023-06-20 | 18,000 | — | $0 | 27,828 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2023-03-31 | 2023-04-04 | 250,000 | — | $0 | 394,090 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2023-03-02 | 2023-03-03 | 5,483 | $5.00 | $27.4K | 144,090 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2023-02-27 | 2023-03-03 | 5,548 | $4.65 | $25.8K | 134,573 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2023-02-27 | 2023-03-03 | 15,000 | — | $0 | 149,573 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2023-02-01 | 2023-02-03 | 10,261 | $4.77 | $48.9K | 182,121 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2023-01-10 | 2023-01-12 | 3,817 | $6.75 | $25.8K | 192,382 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-06-23 | 2022-07-01 | 15,000 | $1.11 | $16.6K | 2,562,003 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-06-22 | 2022-07-01 | 12,000 | $1.09 | $13.1K | 2,577,003 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-06-21 | 2022-07-01 | 21,000 | $1.09 | $22.9K | 2,589,003 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-06-17 | 2022-07-01 | 228,000 | $1.09 | $248.5K | 2,610,003 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-04-13 | 2022-04-22 | 21,258 | $1.51 | $32.1K | 2,838,003 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-04-05 | 2022-04-22 | 14,030 | $1.77 | $24.8K | 2,859,261 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2022-04-04 | 2022-04-22 | 86,353 | $1.79 | $154.6K | 2,873,291 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award deriv | 2022-04-01 | 2022-04-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | F Tax w/h | 2022-02-24 | 2022-04-22 | 117,657 | $1.85 | $217.7K | 2,959,644 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2022-01-31 | 2022-02-02 | 455,000 | — | $0 | 3,608,210 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | F Tax w/h | 2022-01-30 | 2022-04-22 | 31,972 | $2.46 | $78.7K | 3,077,301 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | F Tax w/h | 2022-01-24 | 2022-04-22 | 143,136 | $2.19 | $313.5K | 3,109,273 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | F Tax w/h | 2022-01-06 | 2022-04-22 | 53,024 | $2.77 | $146.9K | 3,252,409 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | F Tax w/h | 2022-01-01 | 2022-04-22 | 302,777 | $3.11 | $941.6K | 3,305,433 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2021-02-05 | 2021-02-05 | 48,790 | $3.42 | $166.9K | 3,153,210 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | S Sale | 2021-02-04 | 2021-02-05 | 70,000 | $3.51 | $245.7K | 3,202,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2021-01-06 | 2021-01-08 | 539,000 | — | $0 | 3,272,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2020-02-24 | 2020-02-25 | 598,000 | — | $0 | 2,733,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2019-01-24 | 2019-01-25 | 485,000 | — | $0 | 2,135,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2018-01-30 | 2018-02-01 | 325,000 | — | $0 | 1,650,000 | SEC↗ |
| CKPT Checkpoint Therapeutics, I | A Award | 2016-12-15 | 2016-12-19 | 325,000 | — | $0 | 1,325,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2015-07-06 | 2015-07-08 | 1,943 | $9.61 | $18.7K | 209,406 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise deriv | 2015-05-12 | 2015-05-12 | 23,278 | — | $0 | 13,966 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise deriv | 2015-05-12 | 2015-05-12 | 18,333 | — | $0 | 0 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2015-05-12 | 2015-05-12 | 23,278 | $2.78 | $64.7K | 211,349 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2015-05-12 | 2015-05-12 | 18,333 | $2.53 | $46.4K | 188,071 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2015-04-06 | 2015-04-08 | 1,878 | $11.68 | $21.9K | 169,738 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2015-01-05 | 2015-01-06 | 5,604 | $13.79 | $77.3K | 171,616 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2015-01-04 | 2015-01-06 | 47,750 | — | $0 | 47,750 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2015-01-04 | 2015-01-06 | 23,875 | — | $0 | 177,220 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-10 | 2014-12-12 | 25,000 | $15.69 | $392.3K | 153,345 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2014-12-10 | 2014-12-12 | 25,000 | $11.22 | $280.5K | 178,345 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-10-03 | 2014-10-07 | 2,694 | $16.14 | $43.5K | 153,345 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-09-08 | 2014-09-10 | 144,237 | $15.88 | $2.29M | 156,039 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-07-07 | 2014-07-09 | 2,054 | $15.75 | $32.4K | 300,276 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-04-03 | 2014-04-07 | 2,087 | $16.46 | $34.4K | 302,330 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-03-21 | 2014-03-21 | 13,444 | $15.11 | $203.1K | 304,417 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-03-20 | 2014-03-21 | 125,000 | $15.04 | $1.88M | 317,861 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2014-03-19 | 2014-03-21 | 36,667 | $2.53 | $92.8K | 529,528 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2014-03-19 | 2014-03-21 | 48,750 | $4.58 | $223.3K | 596,900 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-03-19 | 2014-03-21 | 154,039 | $15.23 | $2.35M | 442,861 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2014-03-19 | 2014-03-21 | 18,622 | $2.78 | $51.8K | 548,150 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-01-03 | 2014-01-06 | 6,309 | $12.57 | $79.3K | 492,861 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2014-01-02 | 2014-01-06 | 53,062 | — | $0 | 53,062 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2014-01-02 | 2014-01-06 | 22,741 | — | $0 | 499,170 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-12-30 | 2013-12-31 | 49,500 | $12.62 | $624.7K | 476,429 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | M Exercise | 2013-12-30 | 2013-12-31 | 30,000 | $4.59 | $137.7K | 506,429 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-12-30 | 2013-12-31 | 30,000 | $12.64 | $379.2K | 476,429 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-12-27 | 2013-12-31 | 30,000 | $12.68 | $380.4K | 525,929 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-10-03 | 2013-10-07 | 1,475 | $10.25 | $15.1K | 555,929 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-07-05 | 2013-07-09 | 1,438 | $7.95 | $11.4K | 557,404 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-05-13 | 2013-05-14 | 29,363 | $8.34 | $244.9K | 558,842 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-04-05 | 2013-04-08 | 1,484 | $6.93 | $10.3K | 588,205 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-01-04 | 2013-01-04 | 10,859 | $2.74 | $29.8K | 589,689 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2013-01-02 | 2013-01-04 | 55,866 | — | $0 | 55,866 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2013-01-02 | 2013-01-04 | 33,520 | — | $0 | 600,548 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-10-03 | 2012-10-05 | 4,973 | $2.72 | $13.5K | 567,028 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-07-03 | 2012-07-06 | 4,559 | $1.99 | $9.1K | 572,001 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2012-05-21 | 2012-05-22 | 400,000 | — | $0 | 576,560 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-04-05 | 2012-04-05 | 5,458 | $1.60 | $8.7K | 176,560 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-01-03 | 2012-01-03 | 7,190 | $2.63 | $18.9K | 182,018 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2012-01-02 | 2012-01-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2012-01-02 | 2012-01-03 | 28,000 | — | $0 | 189,208 | SEC↗ |